Skip to Main Content

Paper Details

A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation.
Crit Care Med
8
2022
Author NameAffiliation
Ayan SenMayo Clinic Arizona
  • 1 - 1

Datasets

Release 1.2